Related Experiment Video
Updated: Sep 22, 2026

Trans-vivo Delayed Type Hypersensitivity Assay for Antigen Specific Regulation
Published on: May 2, 2013
[Non-immunologic factor: immunosuppressive drug-induced nephrotoxicity]
Tatsuya Nakatani1, Toshihiro Asai
1Department of Urology, Osaka City University Graduate School of Medicine.
Insights
Magnesium (Mg) supplementation significantly reduces cyclosporine A (CsA)-induced kidney damage by inhibiting inflammatory cell infiltration and fibrosis. This effect appears independent of the renin-angiotensin system, offering a novel therapeutic strategy for immunosuppressant nephrotoxicity.
Area of Science:
- Nephrology
- Immunology
- Pharmacology
Context:
- Immunosuppressant-induced nephrotoxicity is a major cause of long-term kidney graft loss.
- Cyclosporine A (CsA) is a common immunosuppressant associated with significant nephrotoxicity.
- Magnesium (Mg) deficiency exacerbates CsA nephrotoxicity, but the underlying mechanisms require elucidation.
Purpose:
- To investigate the protective mechanisms of Mg supplementation against CsA-induced nephrotoxicity.
- To examine the role of the renin-angiotensin system (RAS) in CsA nephrotoxicity and Mg's potential modulation of it.
- To elucidate the impact of Mg on CsA-induced interstitial mononuclear cell infiltration and subsequent tubulointerstitial fibrosis.
Summary:
- CsA administration in rats led to impaired renal function, increased tubulointerstitial fibrosis, and elevated expression of chemoattractant proteins (osteopontin, MCP-1).
- Mg supplementation ameliorated CsA-induced renal dysfunction and fibrosis, significantly reducing inflammatory cell infiltration.
- Angiotensin-converting enzyme inhibitor (ACEI) showed limited protective effects, suggesting Mg's benefits are largely independent of the RAS.
Impact:
- Mg supplementation effectively prevents CsA-induced nephrotoxicity by inhibiting inflammatory cell influx and fibrosis, independent of the RAS.
- These findings highlight Mg as a potential therapeutic agent to mitigate long-term kidney damage in patients receiving CsA.
- Understanding this mechanism provides a basis for developing novel strategies to improve kidney graft survival and patient outcomes.
Abstract:
Immunosuppressant-induced nephrotoxicity contributes to kidney graft loss in the long-term as one of the non-immunologic factors. We previously reported that correction of cyclosporine A (CsA)-induced hypomagnesemia reduced chronic CsA nephrotoxicity. This study was conducted to elucidate the mechanism of the beneficial effects of magnesium (Mg) on CsA nephrotoxicity and examine the role of the renin-angiotensin system in this mechanism. We particularly focused on CsA-induced interstitial mononuclear cell infiltration. CsA (15 mg/kg/day, s.c.) was administered daily to rats maintained on low sodium diets for 7, 14 and 28 days. The inhibitory effects of Mg supplementation and those of angiotensin converting enzyme inhibitor (ACEI) were compared for renal function, renal histology, mononuclear cell infiltration and gene expression profile. CsA lowered creatinine clearance and developed characteristic tubulointerstitial fibrosis that were mostly evident at day 28. CsA-induced impairment of renal function was ameliorated by Mg supplementation but not by ACEI. Monocyte/macrophage infiltration preceded the renal fibrosis and increased progressively with the duration of CsA administration. CsA markedly upregulated the expression of chemoattractant proteins, osteopontin and monocyte chemoattractant protein-1, concomitantly. These changes were markedly attenuated by Mg but only slightly by ACEI. CsA also promoted expression of fibrogenic molecules and extracellular matrices that were markedly attenuated by Mg but only slightly by ACEI. Similarly, CsA-induced tubulointestitial fibrosis was almost completely abolished by Mg supplementation but only partially attenuated by ACEI. These results suggested that Mg supplementation abolished CsA-induced precedent inflammatory cell influx possibly via inhibition of expression of chemoattractants and consequently suppressed tubulointerstitial fibrosis. In this beneficial mechanism, factors independent of renin-angiotensin system seem to be mainly involved.
More Related Videos
Related Concept Videos
Renal Failure: Dose Adjustments
Reduced renal clearance and elimination rate are common outcomes of renal impairment. These alterations lead to a prolonged elimination half-life and an altered apparent volume of distribution for drugs. As a result, dosage adjustments are typically necessary to maintain optimal drug levels in the body.
However, dosage adjustments...
Drug Toxicity: Risk factors
Drug Toxicity: Dose-Dependent Reactions
Drug Toxicity: Allergic Reactions
Drug toxicity: Idiosyncratic Reactions
Acute Kidney Injury IV: Diagnostic Studies and Prevention

